Literature DB >> 198105

Benign liver-cell adenoma associated with long-term administration of an androgenic-anabolic steroid (methandienone).

L Hernandez-Nieto, M Bruguera, J Bombi, L Camacho, C Rozman.   

Abstract

A 19-year-old man with paroxysmal nocturnal hemoglobinuria treated for 3 years with Methandienone was admitted to the hospital with hemoperitoneum due to the rupture of an hepatic tumor. Histology revealed that it was a benign liver cell adenoma, with a pathologic appearance and mode of clinical presentation closely resembling those of cases observed to develop in association to contraceptive steroids.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 198105     DOI： 10.1002/1097-0142(197710)40:4<1761::aid-cncr2820400454>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Epidemiological and policy issues in the measurement of the long term health effects of anabolic-androgenic steroids.

Authors:  C E Yesalis; J E Wright; M S Bahrke
Journal:  Sports Med       Date:  1989-09       Impact factor: 11.136

Review 2.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  Androgen associated hepatocellular carcinoma with an aggressive course.

Authors:  D Gleeson; M J Newbould; P Taylor; R F McMahon; B C Leahy; T W Warnes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder.

Authors:  Keizo Kato; Hiroshi Abe; Noriko Hanawa; Junya Fukuzawa; Ryota Matsuo; Takeshi Yonezawa; Sadahiro Itoh; Yoshiyuki Sato; Makiko Ika; Shohei Shimizu; Shinji Endo; Hiroshi Hano; Asami Izu; Masahiko Sugitani; Akihito Tsubota
Journal:  Clin J Gastroenterol       Date:  2018-03-27

Review 5.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report.

Authors:  Aline Hardt; Dirk Stippel; Margarete Odenthal; Arnulf H Hölscher; Hans-Peter Dienes; Uta Drebber
Journal:  Case Rep Pathol       Date:  2012-07-05

7.  Androgen receptor concentrations in the diethylnitrosamine model of hepatic carcinogenesis.

Authors:  P Bannister; M A Parsons; P Ingleton; J C Underwood; M S Losowsky
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

8.  Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.

Authors:  Philipp Solbach; Andrej Potthoff; Hans-Jürgen Raatschen; Bisharah Soudah; Ulrich Lehmann; Andrea Schneider; Michael J Gebel; Michael P Manns; Arndt Vogel
Journal:  BMC Gastroenterol       Date:  2015-05-20       Impact factor: 3.067

9.  Inflammatory hepatocellular adenoma in a patient with Turner's syndrome: A case report.

Authors:  Satoshi Nemoto; Shun-Ichi Ariizumi; Yoshihito Kotera; Akiko Omori; Shingo Yamashita; Taka-Aki Kato; Shota Aoyama; Hiroto Egawa; Masakazu Yamamoto
Journal:  Int J Surg Case Rep       Date:  2019-02-15

Review 10.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.